
Releases
PorTal Access Secures FDA Clearance for FLEXI-PORT Vascular System
The U.S. Food and Drug Administration has granted clearance to PorTal Access for its FLEXI-PORT family of implantable vascular ports, marking the first significant design shift in chemotherapy port technology in over three decades. The system is engineered to provide flexible implantation options for both pediatric and adult patients.






:max_bytes(150000):strip_icc():focal(999x0:1001x2)/ted-danson-oceana-081624-tout-e6bc00c561ec488881fa53ab91e7c18d.jpg)


















